The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Genetic and environmental factors in the cause of Parkinson's disease
Abstract
Despite being the subject of intense study, the pathogenesis of Parkinson's disease still remains unclear. In recent years, however, there has been increasing evidence to support a role for genetic factors in its cause. This has come from twin and family studies, the mapping and cloning of PARK genes that are associated with the development of PD, and analysis of potential susceptibility genes. There is also evidence indicating that environmental factors may play a role in the disease process. It is likely that for most cases, there is a complex interplay between these genetic and environmental influences in the causation of Parkinson's disease. This article reviews the evidence in support of genetic and environmental factors in the cause of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase
Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., et al. (2000) · Nature Genetics · doi:10.1038/77060 · Cited by 2,024 · cited 1×
“terminus and two RING finger domains in its C terminus.(44) Molecular studies have determined that par-”
BackgroundMasliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. M., Dexter, D., Jenner, P., Clark, J. B., & Marsden, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,756
Self-citationMice Lacking α-Synuclein Display Functional Deficits in the Nigrostriatal Dopamine System
Abeliovich, A., Schmitz, Y., Fariñas, I., Choi-Lundberg, D., Ho, W.-H., Castillo, P. E., Shinsky, N., Verdugo, J. M. G., Armanini, M., Ryan, A., et al. (2000) · Neuron · doi:10.1016/s0896-6273(00)80886-7 · Cited by 1,722
The ubiquitin pathway in Parkinson's disease
Leroy, E., Boyer, R., Auburger, G., Leube, B., Ulm, G., Mezey, E., Harta, G., Brownstein, M. J., Jonnalagada, S., Chernova, T., et al. (1998) · Nature · doi:10.1038/26652 · Cited by 1,571
Association between Early-Onset Parkinson's Disease and Mutations in the Parkin Gene
Lücking, C. B., Dürr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B. S., Meco, G., Denèfle, P., Wood, N. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005253422103 · Cited by 1,433
Imai, Y., Soda, M., Inoue, H., Hattori, N., Mizuno, Y., & Takahashi, R. (2001) · Cell · doi:10.1016/s0092-8674(01)00407-x · Cited by 1,050
Zhang, Y., Gao, J., Chung, K. K. K., Huang, H., Dawson, V. L., & Dawson, T. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240347797 · Cited by 982
Parkinson Disease in Twins: An Etiologic Study
Tanner, C. M., Ottman, R., Goldman, S. M., Ellenberg, J., Chan, P., Mayeux, R., & Langston, J. W. (1999) · JAMA · doi:10.1001/jama.281.4.341 · Cited by 867
George, J. M., Jin, H., Woods, W. S., & Clayton, D. F. (1995) · Neuron · doi:10.1016/0896-6273(95)90040-3 · Cited by 844
Mapping of a gene for Parkinson's disease to chromosome 4q21-q23
Polymeropoulos, M. H., Higgins, J. J., Golbe, L. I., Johnson, W. G., Ide, S. E., Di Iorio, G., Sanges, G., Stenroos, E. S., Pho, L. T., Schaffer, A. A., et al. (1996) · Science · doi:10.1126/science.274.5290.1197 · Cited by 788 · cited 2×
“Linkage to markers on chromosome 4q21-q23 was demonstrated and the locus was designated PARK1.(26) Further analysis identified a mutation in exon 4 of the”
BackgroundA new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2–q13.1
Funayama, M., Hasegawa, K., Kowa, H., Saito, M., Tsuji, S., & Obata, F. (2002) · Annals of Neurology · doi:10.1002/ana.10113 · Cited by 667
Origin and functional consequences of the complex I defect in Parkinson's disease
Swerdlow, R. H., Parks, J. K., Miller, S. W., Davis, R. E., Tuttle, J. B., Trimmer, P. A., Sheehan, J. P., Bennett, J. P., & Parker, W. D. (1996) · Annals of Neurology · doi:10.1002/ana.410400417 · Cited by 638
Advances in Our Understanding of the Mechanisms of the Neurotoxicity of MPTP and Related Compounds
Tipton, K. F., & Singer, T. P. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb13610.x · Cited by 539
Abbas, N., Lucking, C. B., Ricard, S., Durr, A., Bonifati, V., De Michele, G., Bouley, S., Vaughan, J. R., Gasser, T., Marconi, R., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.567 · Cited by 530
Valente, E. M., Bentivoglio, A. R., Dixon, P. H., Ferraris, A., Ialongo, T., Frontali, M., Albanese, A., & Wood, N. W. (2001) · The American Journal of Human Genetics · doi:10.1086/319522 · Cited by 493
Mutations in NR4A2 associated with familial Parkinson disease
Le, W.-D., Xu, P., Jankovic, J., Jiang, H., Appel, S. H., Smith, R. G., & Vassilatis, D. K. (2003) · Nature Genetics · doi:10.1038/ng1066 · Cited by 487
A susceptibility locus for Parkinson's disease maps to chromosome 2p13
Gasser, T., Müller-Myhsok, B., Wszolek, Z. K., Oehlmann, R., Calne, D. B., Bonifati, V., Bereznai, B., Fabrizio, E., Vieregge, P., & Horstmann, R. D. (1998) · Nature Genetics · doi:10.1038/ng0398-262 · Cited by 458
Parkinson's disease and exposure to agricultural work and pesticide chemicals
Semchuk, K. M., Love, E. J., & Lee, R. G. (1992) · Neurology · doi:10.1212/wnl.42.7.1328 · Cited by 439
Seidler, A., Hellenbrand, W., Robra, B.-P., Vieregge, P., Nischan, P., Joerg, J., Oertel, W. H., Ulm, G., & Schneider, E. (1996) · Neurology · doi:10.1212/wnl.46.5.1275 · Cited by 433
Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease
Smith, C. A. D., Wolf, C. R., Gough, A. C., Spurr, N. K., Leigh, P. N., Summers, B. A., Harding, A. E., Maranganore, D. M., Sturman, S. G., Williams, A. C., et al. (1992) · The Lancet · doi:10.1016/0140-6736(92)91196-f · Cited by 417
Self-citationA large kindred with autosomal dominant Parkinson's disease
Golbe, L. I., Di Iorio, G., Bonavita, V., Miller, D. C., & Duvoisin, R. C. (1990) · Annals of Neurology · doi:10.1002/ana.410270309 · Cited by 412
The septin CDCrel-1 binds syntaxin and inhibits exocytosis
Beites, C. L., Xie, H., Bowser, R., & Trimble, W. S. (1999) · Nature Neuroscience · doi:10.1038/8100 · Cited by 377
Matsumine, H., Saito, M., Shimoda‐Matsubayashi, S., Tanaka, H., Ishikawa, A., Nakagawa-Hattori, Y., Yokochi, M., Kobayashi, T., Igarashi, S., Takano, H., et al. (1997) · Europe PMC (PubMed Central) · Cited by 377
Parkinson's disease in 65 pairs of twins and in a set of quadruplets
Ward, C. D., Duvoisin, R. C., Ince, S. E., Nutt, J. D., Eldridge, R., & Calne, D. B. (1983) · Neurology · doi:10.1212/wnl.33.7.815 · Cited by 348
alpha-synuclein gene haplotypes are associated with Parkinson's disease
Farrer, M. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.17.1847 · Cited by 340
THE SIGNIFICANCE OF THE LEWY BODY IN THE DIAGNOSIS OF IDIOPATHIC PARKINSON'S DISEASE
GIBB, W. R. G., & LEES, A. J. (1989) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1989.tb01147.x · Cited by 319
Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease
Gu, M., Cooper, J. M., Taanman, J. W., & Schapira, A. H. V. (1998) · Annals of Neurology · doi:10.1002/ana.410440207 · Cited by 313
Self-citationPiccini, P., Burn, D. J., Ceravolo, R., Maraganore, D., & Brooks, D. J. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199905)45:5<577::aid-ana5>3.0.co;2-o · Cited by 304
Complete Genomic Screen in Parkinson Disease: Evidence for Multiple Genes
Scott, W. K., Nance, M. A., Watts, R. L., Hubble, J. P., Koller, W. C., Lyons, K., Pahwa, R., Stern, M. B., Colcher, A., Hiner, B. C., et al. (2001) · JAMA · doi:10.1001/jama.286.18.2239 · Cited by 282
Kr�ger, R., Menezes Vieira-Saecker, A. M., Kuhn, W., Berg, D., M�ller, T., K�hnl, N., Fuchs, G. A., Storch, A., Hungs, M., Woitalla, D., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199905)45:5<611::aid-ana9>3.0.co;2-x · Cited by 277
Familial Aggregation of Parkinson's Disease in Iceland
Sveinbjörnsdóttir, S., Hicks, A. A., Jónsson, T., Pétursson, H., Guðmundsson, G., Frigge, M. L., Kong, A., Gulcher, J. R., & Stefánsson, K. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012143432404 · Cited by 275
Familial juvenile Parkinsonism.
Carlier, G., & Jm, D. (1979) · PubMed · Cited by 261
Familial juvenile parkinsonism: Clinical and pathologic study in a family
Takahashi, H., Ohama, E., Suzuki, S., Horikawa, Y., Ishikawa, A., Morita, T., Tsuji, S., & Ikuta, F. (1994) · Neurology · doi:10.1212/wnl.44.3_part_1.437 · Cited by 258
A chromosome 4p haplotype segregating with Parkinson's disease and postural tremor
Farrer, M. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.1.81 · Cited by 248
Fall, P.-A., Fredrikson, M., Axelson, O., & Gran�rus, A.-K. (1999) · Movement Disorders · doi:10.1002/1531-8257(199901)14:1<28::aid-mds1007>3.0.co;2-o · Cited by 244
Mutant debrisoquine hydroxylation genes in Parkinson's disease
Armstrong, M., Daly, A. K., Cholerton, S., Idle, J. R., & Bateman, D. N. (1992) · The Lancet · doi:10.1016/0140-6736(92)90537-d · Cited by 236
Clinical genetic analysis of Parkinson's disease in the contursi kindred
Golbe, L. I., Lazzarini, A. M., Duvoisin, R. C., Iorio, G. D., Sanges, G., Bonavita, V., & la Sala, S. (1996) · Annals of Neurology · doi:10.1002/ana.410400513 · Cited by 236
Ishikawa, A., & Tsuji, S. (1996) · Neurology · doi:10.1212/wnl.47.1.160 · Cited by 233
Recent advances in the genetics and pathogenesis of Parkinson disease
Mouradian, M. M. (2002) · Neurology · doi:10.1212/wnl.58.2.179 · Cited by 228
Variability and validity of polymorphism association studies in Parkinson’s disease
Tan, E. K., Khajavi, M., Thornby, J. I., Nagamitsu, S., Jankovic, J., & Ashizawa, T. (2000) · Neurology · doi:10.1212/wnl.55.4.533 · Cited by 219
Case-control study of the ubiquitin carboxy-terminal hydrolase L1 gene in Parkinson’s disease
Maraganore, D. M., Farrer, M. J., Hardy, J. A., Lincoln, S. J., McDonnell, S. K., & Rocca, W. A. (1999) · Neurology · doi:10.1212/wnl.53.8.1858 · Cited by 209
Momose, Y., Murata, M., Kobayashi, K., Tachikawa, M., Nakabayashi, Y., Kanazawa, I., & Toda, T. (2002) · Annals of Neurology · doi:10.1002/ana.10079 · Cited by 198
EPIDEMIOLOGY of PARKINSON'S DISEASE IN FINLAND
MABTRILA, R. J., & RINNE, U. K. (1976) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1976.tb04328.x · Cited by 196
Association of Single-Nucleotide Polymorphisms of the Tau Gene With Late-Onset Parkinson Disease
Martin, E. R. (2001) · JAMA · doi:10.1001/jama.286.18.2245 · Cited by 191
Ecogenetics of Parkinson's Disease: Prevalence and Environmental Aspects in Rural Areas
Barbeau, A., Roy, M., Bernier, G., Campanella, G., & Paris, S. (1987) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100026147 · Cited by 174
Kimpara, T., Takeda, A., Watanabe, K., Itoyama, Y., Ikawa, S., Watanabe, M., Arai, H., Sasaki, H., Higuchi, S., Okita, N., et al. (1997) · Human Genetics · doi:10.1007/s004390050480 · Cited by 169
Positron emission tomographic evidence for progression of human MPTP‐induced dopaminergic lesions
Vingerhoets, F. J. G., Snow, B. J., Tetrud, J. W., Langston, J. W., Schulzer, M., & Calne, D. B. (1994) · Annals of Neurology · doi:10.1002/ana.410360513 · Cited by 151
A clinical genetic study of Parkinson's disease
Lazzarini, A. M., Myers, R. H., Zimmerman, T. R., Mark, M. H., Golbe, L. I., Sage, J. I., Johnson, W. G., & Duvoisin, R. C. (1994) · Neurology · doi:10.1212/wnl.44.3_part_1.499 · Cited by 137
Parkinson's disease in a nationwide twin cohort
Marttila, R. J., Kaprio, J. A., Koskenvuo, M., & Rinne, U. K. (1988) · Neurology · doi:10.1212/wnl.38.8.1217 · Cited by 132
Twin studies and the genetics of Parkinson's disease—a reappraisal
Johnson, W. G., Hodge, S. E., & Duvoisin, R. C. (1990) · Movement Disorders · doi:10.1002/mds.870050302 · Cited by 130
Piccini, P. P., Morrish, P., Turjanski, N., Sawle, G. V., Burn, D. J., Weeks, R. A., Mark, M. H., Maraganore, D. M., Lees, A. J., & Brooks, D. J. (1997) · Annals of Neurology · doi:10.1002/ana.410410213 · Cited by 125
Genetics of Parkinson's disease
Gasser, T. (2001) · Journal of Neurology · doi:10.1007/s004150170066 · Cited by 124
Harada, S., Fujii, C., Hayashi, A., & Ohkoshi, N. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5868 · Cited by 123
Twin study of Parkinson disease
Duvoisin, R. C., Eldridge, R., Williams, A. C., Nutt, J. G., & Calne, D. B. (1981) · Neurology · doi:10.1212/wnl.31.1.77 · Cited by 121
Association of slow acetylator genotype for N-acetyltransferase 2 with familial Parkinson's disease
Bandmann, O., Vaughan, J. R., Holmans, P., MARSDEN, C. D., & Wood, N. W. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03495-8 · Cited by 120
Association of homozygous 7048G7049 variant in the intron six of Nurr1 gene with Parkinson’s disease
Xu, P., Liang, R., Jankovic, J. J., Hunter, C., Zeng, Y.-X., Ashizawa, T., Lai, D., & Le, W. (2002) · Neurology · doi:10.1212/wnl.58.6.881 · Cited by 118
Vaughan, J. R. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.4.751 · Cited by 116
Lincoln, S., Vaughan, J. R., Wood, N., Baker, M. C., Adamson, J. L., Gwinn, K. A., Lynch, T., Hardy, J., & Farrer, M. J. (1999) · Neuroreport · doi:10.1097/00001756-199902050-00040 · Cited by 115
Genetics of Parkinson's disease.
Gasser, T. (2004) · Europe PMC (PubMed Central) · Cited by 111
PARK6-linked parkinsonism occurs in several European families.
Valente, E. M., Brancati, F., Ferraris, A., Graham, E. A., Davis, M. B., Breteler, M. M. B., Gasser, T., Bonifati, V., Bentivoglio, A. R., Michele, G. D., et al. (2002) · PubMed · Cited by 110
Semchuk, K. M., Love, E. J., & Lee, R. G. (1991) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100031826 · Cited by 109
Park6‐linked parkinsonism occurs in several european families
Valente, E. M., Brancati, F., Ferraris, A., Graham, E. A., Davis, M. B., Breteler, M. M. B., Gasser, T., Bonifati, V., Bentivoglio, A. R., Michele, G. D., et al. (2001) · Annals of Neurology · doi:10.1002/ana.10053 · Cited by 107
Association of a polymorphism in the dopamine‐transporter gene with parkinson's disease
Couteur, D. G. L., Leighton, P. W., McCann, S. J., & Pond, S. M. (1997) · Movement Disorders · doi:10.1002/mds.870120523 · Cited by 95
Martin, W. E., Young, W. I., & Anderson, V. E. (1973) · Brain · doi:10.1093/brain/96.3.495 · Cited by 95
Chan, P., Tanner, C. M., Jiang, X. M., & Langston, J. W. (1998) · Neurology · doi:10.1212/wnl.50.2.513 · Cited by 93
Maternal inheritance in Parkinson's disease
Wooten, G. F., Currie, L. J., Bennett, J. P., Harrison, M. B., Trugman, J. M., & Parker, W. D. (1997) · Annals of Neurology · doi:10.1002/ana.410410218 · Cited by 93
Genome-wide scan for Parkinson's disease
DeStefano, A. L., Golbe, L. I., Mark, M. H., Lazzarini, A. M., Maher, N. E., Saint‐Hilaire, M., Feldman, R. G., Guttman, M., Watts, R. L., Suchowersky, O., et al. (2001) · Neurology · doi:10.1212/wnl.57.6.1124 · Cited by 87
Planté‐Bordeneuve, V., Taussig, D., Thomas, F., Said, G., Wood, N. W., MARSDEN, C. D., & Harding, A. E. (1997) · Neurology · doi:10.1212/wnl.48.6.1589 · Cited by 79
Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease
Hotamışlıgil, G. S., Girmen, A. S., Fink, J. S., Tivol, E. A., Shalish, C., Trofatter, J. A., Baenziger, J. C., Diamond, S. G., Markham, C. H., Sullivan, J. L., et al. (1994) · Movement Disorders · doi:10.1002/mds.870090304 · Cited by 78
Mutation, sequence analysis, and association studies of α-synuclein in Parkinson's disease
Parsian, A., Racette, B. A., Zhang, Z. H., Chakraverty, S., Rundle, M. M., Goate, A., & Perlmutter, J. S. (1998) · Neurology · doi:10.1212/wnl.51.6.1757 · Cited by 72
Harhangi, B. S., Farrer, M. J., Lincoln, S., Bonifati, V., Meco, G., Michele, G. D., Brice, A., Dürr, A., Martinez, M. M., Gasser, T., et al. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00465-6 · Cited by 72
A Manual of Diseases of the Nervous System.
(1899) · JAMA · doi:10.1001/jama.1899.02450640058025 · Cited by 60
Catechol-O-methyltransferase genotype and susceptibility to Parkinson's disease in Japan
Yoritaka, A., Hattori, N., Yoshino, H., & Mizuno, Y. (1997) · Journal of Neural Transmission · doi:10.1007/bf01294732 · Cited by 54
Nanko, S., Ueki, A., Hattori, M., Dai, X. Y., Sasaki, T., Fukuda, R., Ikeda, K., & Kazamatsuri, H. (1994) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320540415 · Cited by 52
Slow allotypic variants of the NAT2 gene and susceptibility to early-onset Parkinson's disease
Agúndez, J. A. G., Jiménez‐Jiménez, F. J., Luengo, A., Molina, J. A., Pareja, M. O., Vázquez, A., Ramos, F., Duarte, J., Coria, F., Ladero, J. M., et al. (1998) · Neurology · doi:10.1212/wnl.51.6.1587 · Cited by 50
G/A1947 polymorphism in catechol‐O‐methyltransferase (COMT) gene in Parkinson's disease
Xie, T., Ho, S. L., Li, L. S. W., & Ma, O. C. K. (1997) · Movement Disorders · doi:10.1002/mds.870120325 · Cited by 48
The dopamine transporter gene and Parkinson's disease in a Chinese population
Leighton, P. W., Couteur, D. G. L., Pang, C. C. P., McCann, S. J., Chan, D. K. Y., Law, L. K., Kay, R., Pond, S. M., & Woo, J. (1997) · Neurology · doi:10.1212/wnl.49.6.1577 · Cited by 47
Whitehead, A. S., Bertrandy, S., Finnan, F., Butler, A., Smith, G. D., & Ben‐Shlomo, Y. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.4.347 · Cited by 44
Genetic association between cytochrome P450IA1 gene and susceptibility to Parkinson's disease
Takakubo, F., Yamamoto, M., Ogawa, N., Yamashita, Y., Mizuno, Y., & Kondo, I. (1996) · Journal of Neural Transmission · doi:10.1007/bf01273362 · Cited by 39
Gasser, T., Müller‐Myhsok, B., Supala, A., Luedecking‐Zimmer, E., Wieditz, G., Wszołek, Z. K., Vieregge, P., Bonifati, V., & Oertel, W. H. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.5.518 · Cited by 35
Warner, T. T., & Schapira, A. H. V. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.3.378 · Cited by 34
Self-citationDegl'Innocenti, F., Maurello, M. T., & Marini, P. (1989) · Neurological Sciences · doi:10.1007/bf02333776 · Cited by 27
Nicholl, D. J., Vaughan, J. R., Khan, N. L., Ho, S. L., Aldous, D. E. W., Lincoln, S. J., Farrer, M. J., Gayton, J., Davis, M. B., Piccini, P. P., et al. (2002) · Brain · doi:10.1093/brain/awf013 · Cited by 27
The Role of the Environment in Parkinson's Disease
Gorell, J. M., Monte, D. A. D., & Graham, D. G. (1996) · Environmental Health Perspectives · doi:10.1289/ehp.96104652 · Cited by 26
N-acetyltransferase-2 polymorphism in Parkinson's disease: the Rotterdam study
Harhangi, B. S., Oostra, B. A., Heutink, P., van Duijn, C. M., Albert Hofman, D., & Breteler, M. M. B. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.4.518 · Cited by 25
Advances in the Understanding of the Cause of Parkinson's Disease
Schapira, A. H. V. (1994) · Journal of the Royal Society of Medicine · doi:10.1177/014107689408700701 · Cited by 2
Self-citation
Cited by
Molecular Pathways of Neurodegeneration in Parkinson's Disease
Dawson, T. M., & Dawson, V. L. (2003) · Science · doi:10.1126/science.1087753 · Cited by 1,663
Satake, W., Nakabayashi, Y., Mizuta, I., Hirota, Y., Ito, C., Kubo, M., Kawaguchi, T., Tsunoda, T., Watanabe, M., Takeda, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.485 · Cited by 1,324
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
Schapira, A. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70327-7 · Cited by 883
Self-citationA review of Parkinson's disease
Davie, C. A. (2008) · British Medical Bulletin · doi:10.1093/bmb/ldn013 · Cited by 855
Etiology and pathogenesis of Parkinson's disease
Schapira, A. H., & Jenner, P. (2011) · Movement Disorders · doi:10.1002/mds.23732 · Cited by 657
Self-citation
Metadata
- Authors
- Warner, T. T., & Schapira, A. H. V.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2003
- Volume
- 53
- Issue
- S3
- Pages
- S16-S25
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2116819366
- Cited by
- 399
- References
- 94
- FWCI
- 14.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.